Bottom line
How much do FHLC and FSPHX overlap?
48% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 49.8% of FHLC's assets and 38.1% of FSPHX's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 152), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and FSPHX have in common
| Holding | % of FHLC | % of FSPHX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 8.03% | 8.03% |
| Johnson & Johnson | 8.93% | 4.91% | 4.91% |
| AbbVie Inc | 6.42% | 2.03% | 2.03% |
| UnitedHealth Group Inc | 5.44% | 3.49% | 3.49% |
| Merck & Co Inc | 4.66% | 1.60% | 1.60% |
| Thermo Fisher Scientific Inc | 3.09% | 4.33% | 3.09% |
| Gilead Sciences Inc | 2.34% | 2.21% | 2.21% |
| CVS Health Corp | 1.92% | 1.29% | 1.29% |
| Danaher Corp | 1.80% | 6.89% | 1.80% |
| Boston Scientific Corp | 1.00% | 2.17% | 1.00% |
| Cencora Inc | 0.83% | 1.14% | 0.83% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Pfizer Inc — 2.06%
- Bristol-Myers Squibb Co — 1.93%
- Intuitive Surgical Inc — 1.82%
- Vertex Pharmaceuticals Inc — 1.76%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- McKesson Corp — 1.52%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- HCA Healthcare Inc — 0.91%
- Cardinal Health Inc — 0.78%
Only in FSPHX
- Alnylam Pharmaceuticals Inc — 2.40%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
- Ucb Sa — 2.03%
- Bio Techne Corp — 1.70%
- Argenx Se — 1.56%
- Nuvalent Inc — 1.28%
- Natera Inc — 1.27%
- Brightspring Health Services Inc — 1.23%
- Viatris Inc — 1.20%
- Moderna Inc — 1.18%
- West Pharmaceutical Svcs Inc — 1.12%
- Agilent Technologies Inc — 1.10%
- Edwards Lifesciences Corp — 1.09%
Asset mix
| Asset type | FHLC | FSPHX |
|---|---|---|
| Stocks | 99.7% | 97.7% |
| Cash & short-term funds | 0.2% | 2.4% |
| Preferred stock | — | 2.0% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | FHLC | FSPHX |
|---|---|---|
| US | 96.5% | 87.0% |
| NL | 0.1% | 2.4% |
| IE | 2.2% | 1.0% |
| DK | — | 2.2% |
| GB | 0.5% | 2.1% |
| BE | — | 2.0% |
| CH | 0.1% | 1.4% |
| KY | — | 1.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FHLC and FSPHX overlap?
What stocks do FHLC and FSPHX have in common?
Should I own both FHLC and FSPHX?
Which holds more stocks, FHLC or FSPHX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.